GlycoRNA-L and glycoRNA-S mediate human monocyte adhesion via binding to Siglec-5

Mingui Fu,Yisong Qian,Evan Huang,Zain Schwartz,Hannah Tai,Katherine Tillock,Tianhua Lei
DOI: https://doi.org/10.1101/2024.08.27.609838
2024-08-27
Abstract:It was recently reported that RNAs can be glycosylated, and a majority of such glycosylated RNAs (referred to as glycoRNAs) are located on the outer cell surface. We here reported that there are two forms of glycoRNAs, named as glycoRNA-L and glycoRNA-S, robustly expressed in human monocytes. Both of glycoRNA-L and glycoRNA-S contributed to the interaction of human monocytes and endothelial cells via directly binding to Siglec-5. GlycoRNA-L predominantly expressed in most of tissues and cell lines. GlycoRNA-S only expressed in some cell lines and tissues. Siglec-5 preferentially binds to glycoRNA-L than glycoRNA-S. The composition of glycan chains in glycoRNA-L and glycoRNA-S is different. GlycoRNA-L contains more sialic acid, whereas glycoRNA-S contains more GlcNAc. Together, these results demonstrate that two forms of glycoRNAs exist, which may play significant role in controlling the interaction of human monocytes and endothelial cells and contribute to the pathogenesis of inflammatory diseases.
Cell Biology
What problem does this paper attempt to address?
The main issue this paper attempts to address is the exploration of the expression of two forms of glycosylated RNA (glycoRNA-L and glycoRNA-S) in human monocytes and their impact on the interaction between monocytes and endothelial cells. Specifically, the researchers found that these two glycosylated RNAs mediate the adhesion of human monocytes by directly binding to Siglec-5, which may be involved in the occurrence and development of inflammatory diseases. Additionally, the study revealed differences in the expression of glycoRNA-L and glycoRNA-S in different tissues and cell lines, as well as differences in their glycan compositions. These findings provide new perspectives for further understanding the molecular mechanisms of cell-cell interactions during inflammation.